(MENAFN- EIN Presswire) Companies like Boston Scientific, Penumbra, and Stryker are advancing thrombectomy devices, enhancing diagnosis and improving patient outcomes. LAS VEGAS , NV, UNITED ...
Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...
Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.
Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional ...
After the MedTech giant Stryker (NYSE:SYK) agreed to offer $4.9B in cash to acquire Inari Medical (NASDAQ:NARI), a maker of ...
Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at $4.9 billion.
Countries committed to rolling out endovascular thrombectomy services are meeting with varying degrees of success.
Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of ...
Contego’s portfolio includes the Neuroguard carotid stent system and Excipio thrombectomy devices. The Neuroguard system is ...
Two new trials saw no impact of thrombolytics in reducing disability at 90 days, but some positive signals offer hope.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback